Divya Yadav, MD

Cancer Focus:
Hodgkin Lymphoma, Meningioma, Neuroendocrine Tumor, Non-Hodgkin Lymphoma, Prostate Cancer

Dr. Yadav received her MD degree from All India Institute of Medical Sciences, New Delhi. She most recently completed a Nuclear Medicine Residency at New York Presbyterian Hospital/Weill Cornell Medicine, where she also served as Chief Resident.

Dr. Yadav’s clinical focus is on therapeutics using targeted radionuclide therapies for prostate, neuroendocrine, and thyroid cancers. Her research interests are utilizing newer radiotracers, including fibroblast activation protein inhibitor (FAPI) and hypoxia imaging, for imaging and treating various oncologic conditions. Her research focus on investigating the clinical use of dosimetry in personalized radionuclide treatment in prostate cancer patients.

• Yadav D, Knight-Greenfield A, Moirano J, Nordvig A, Salgado MW, Hamed M, Lin M, RoyChoudhury A, Blum S, Keil SA, Intorcia B, Ebani EJ, Osborne J, Chiang G, Ivanidze J. Amyloid PET Z Score Quantification and Correlation with Visual Semiquantitative Grading. AJNR Am J Neuroradiol. 2026 May.47(5):1373-1379. Pubmedid: 41198224. Pmcid: PMC13138560.
• Ebani EJ, Yadav D, Knight-Greenfield A, Gardella J, Moirano J, Intorcia B, RoyChoudhury A, Keil SA, Nordvig AS, Blum S, Lin M, Osborne JR, Chiang GC, Ivanidze J. Cross-Platform Concordance of Quantitative Amyloid PET Z-Scores in a Real-World Clinical Cohort of Patients with Cognitive Impairment and Suspected Alzheimer Disease. AJNR Am J Neuroradiol. 2026 Apr. Pubmedid: 41986146.
• Kumar P, Wu K, Prevedello D, Dodson E, Ivanidze J, Yadav D, Upadhyay R, Knisely JPS, Adunka O, Jones T, Thomas EM, Raval RR, Beyer S, Tang B, Palmer JD. Prostate Specific Membrane Antigen Positron Emission Tomography in Management of Vestibular Schwannoma. Pract Radiat Oncol. 2025 Nov.15(6):e540-e544. Pubmedid: 40118177.
• Yadav D, O'Dwyer E, Agee M, Dutruel SP, Mahajan S, Huicochea Castellanos S. Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons. J Imaging. 2025 Feb.11(2). Pubmedid: 39997565. Pmcid: PMC11856187.
• Ricaurte-Fajardo A, Marulanda-Corzo V, Ruder S, Cardoza-Ochoa DR, Granados CE, Yadav D, López-Delgado D, Fatima M, Dutruel S, O'Dwyer E, Osborne JR, Tagawa ST, Huicochea Castellanos S. Revolutionizing prostate cancer treatment: PSMA-targeted therapy in modern therapeutics. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Aug.44(5):500162. Pubmedid: 40403928.
• Yadav D, Dutruel SP, O'Dwyer E, Ricaurte-Fajardo A, Upadhyay R, Palmer JD, Pannullo SC, Tagawa ST, Knisely JPS, Brandmaier A, Osborne JR, Ivanidze J. PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer. Eur J Radiol. 2024 Nov.180:111711. Pubmedid: 39226675.
• Yadav D, Upadhyay R, Kumar VA, Chen MM, Johnson JM, Langshaw H, Curl BJ, Farhat M, Talpur W, Beckham TH, Yeboa DN, Swanson TA, Ghia AJ, Li J, Chung C. Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas. Pract Radiat Oncol. 2024 Nov.14(6):e449-e457. Pubmedid: 38685448.
• Chakrabarty S, Abidi SA, Mousa M, Mokkarala M, Hren I, Yadav D, Kelsey M, LaMontagne P, Wood J, Adams M, Su Y, Thorpe S, Chung C, Sotiras A, Marcus DS. Integrative Imaging Informatics for Cancer Research: Workflow Automation for Neuro-Oncology (I3CR-WANO). JCO Clin Cancer Inform. 2023 May.7:e2200177. Pubmedid: 37146265. Pmcid: PMC10281444.
• Wagner DT, Tilmans L, Peng K, Niedermeier M, Rohl M, Ryan S, Yadav D, Takacs N, Garcia-Fraley K, Koso M, Dikici E, Prevedello LM, Nguyen XV. Artificial Intelligence in Neuroradiology: A Review of Current Topics and Competition Challenges. Diagnostics (Basel). 2023 Aug.13(16). Pubmedid: 37627929. Pmcid: PMC10453240.
• Yadav D, Hwang H, Qiao W, Upadhyay R, Chapin BF, Tang C, Aparicio A, Lopez-Olivo MA, Kang SK, Macapinlac HA, Bathala TK, Surasi DS. 18F-Fluciclovine versus PSMA PET Imaging in Primary Tumor Detection during Initial Staging of High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis. Radiol Imaging Cancer. 2022 Mar.4(2):e210091. Pubmedid: 35212559. Pmcid: PMC8965534.
• Yadav D, Kumar R, Phulia A, Basu S, Alavi A. Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers. PET Clin. 2022 Jul.17(3):399-413. Pubmedid: 35717099.
• Aminu M, Yadav D, Hong L, Young E, Edelkamp P, Saad M, Salehjahromi M, Chen P, Sujit SJ, Chen MM, Sabloff B, Gladish G, de Groot PM, Godoy MCB, Cascone T, Vokes NI, Zhang J, Brock KK, Daver N, Woodman SE, Tawbi HA, Sheshadri A, Lee JJ, Jaffray D, D Code Team, Wu CC, Chung C, Wu J. Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19. Cancers (Basel). 2022 Dec.15(1). Pubmedid: 36612278. Pmcid: PMC9818576.
• Upadhyay R, Yadav D, Venkatesulu BP, Singh R, Baliga S, Raval RR, Lazow MA, Salloum R, Fouladi M, Mardis ER, Zaorsky NG, Trifiletti DM, Paulino AC, Palmer JD. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022 Aug.12:893855. Pubmedid: 36033525. Pmcid: PMC9413159.
• Yadav D, Shah K, Naidoo K, Sudha Surasi DS. PET/Computed Tomography in Thyroid Cancer. Neuroimaging Clin N Am. 2021 Aug.31(3):345-357. Pubmedid: 34243869.
• Yadav D, Kumar R. Critical Role of 2-[18F]-fluoro-2-deoxy-glucose in Hormonally Active Malignancies. PET Clin. 2021 Apr.16(2):177-189. Pubmedid: 33648663.
• Pandey AK, Santosh Y, Sharma PD, Yadav D, Bal C, Kumar R. Restoration of I-131 whole body image using a Wiener filter. Nucl Med Commun. 2020 May.41(5):426-435. Pubmedid: 32187161.
• Yadav D, Angamuthu M, Subudhi TK, Das CJ, Kumar R. PET/CT in Evaluation of Low Backache Due to Sacral Nerve Root Involvement: Inflammatory and Malignant Involvement. Clin Nucl Med. 2020 Jun.45(6):e299-e300. Pubmedid: 32349090.
• Yadav D, Kumar R, Rastogi S, Shamim SA. Pelvic Leiomyosarcoma With Splenic Metastasis and Response Assessment by 18F-FDG PET/CT. Clin Nucl Med. 2020 Jul.45(7):547-548. Pubmedid: 32404703.
• Yadav D, Seth R, Shamim SA, Kumar R. Metabolic Resolution of Lytic Lesions in Erdheim-Chester Disease on 18F-FDG PET/CT. Clin Nucl Med. 2020 Dec.45(12):e514-e515. Pubmedid: 32604106.
• Rojulpote C, Mehdizadeh Seraj S, Zirakchian Zadeh M, Yadav D, Raynor WY, Kothekar E, Al-Zaghal A, Werner TJ, Gerke O, Høilund-Carlsen PF, Alavi A. Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic Uptake. Asia Ocean J Nucl Med Biol. 2020 Dec.8(1):36-45. Pubmedid: 32064281. Pmcid: PMC6994784.
• Yadav D, Ballal S, Yadav MP, Tripathi M, Roesch F, Bal C. Evaluation of [68Ga]Ga-DATA-TOC for imaging of neuroendocrine tumours: comparison with [68Ga]Ga-DOTA-NOC PET/CT. Eur J Nucl Med Mol Imaging. 2020 Apr.47(4):860-869. Pubmedid: 31754796.
• Arora S, Damle NA, Meel R, Sharma S, Sen S, Bal C, Lata K, Prakash S, Yadav D, Angamuthu M. Orbital IgG4 Disease: Imaging Findings on 68Ga-DOTANOC PET/CT. Nucl Med Mol Imaging. 2019 Dec.53(6):432-435. Pubmedid: 31867079. Pmcid: PMC6898689.
• Tulsyan S, Tripathi M, Das K, Yadav D, Shamim SA, Damle N, Bal C. Tc-99m Sulfur Colloid Lymphoscintigraphy with Single-photon Emission Computed Tomography/Computed Tomography in a Case of Acquired Vulval Lymphangiomas. Indian J Nucl Med. 2017 Jan.32(1):73-74. Pubmedid: 28242996. Pmcid: PMC5317082.